GSA Capital Partners’s Corvus Pharmaceuticals CRVS Stock Holding History

GSA Capital Partners’s Portfolio CRVS Stock Details CRVS Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell
2025 Q4	$109K	Sell
2025 Q3	$2.96M	Buy
2025 Q2	$1.27M	Buy
2025 Q1	–	Sell
2024 Q4	$193K	Buy
2021 Q2	–	Sell
2021 Q1	$294K	Buy